HOW WELL DOES ULTRASOUND-ASSESSED SYNOVITIS IN REDUCED JOINT SETS PREDICT THE RESPONSE TO SECUKINUMAB IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS AND INADEQUATE RESPONSE TO CONVENTIONAL DMARDS? - EXPLORATORY RESULTS FROM A PHASE 3B STUDY

被引：0

作者：

D'agostino, M. A. ^{[1
]}

Conaghan, P. G. ^{[2
]}

Gaillez, C. ^{[3
]}

Naredo, E. ^{[4
]}

Mandl, P. ^{[5
]}

Carron, P. ^{[6
]}

Senolt, L. ^{[7
,8
]}

Rosa, J. ^{[9
]}

Lopez-Rodriguez, A. ^{[10
]}

Goyanka, P. ^{[11
]}

Sahoo, B. G. ^{[12
]}

Bao, W. ^{[13
]}

Schett, G. ^{[14
]}

Boers, M. ^{[15
]}

机构：

[1] Univ Cattolica Sacro Cuore, Rheumatol, Rome, Italy

[2] Univ Leeds, Rheumatol, London, England

[3] Novartis Pharma AG, Immunol & Rheumatol, Basel, Switzerland

[4] Hosp Fdn Jimenez Diaz & Autonoma Univ, Dept Rheumatol & Joint & Bone Res Unit, Madrid, Spain

[5] Med Univ Vienna, Div Rheumatol, Vienna, Austria

[6] Ghent Univ Hosp, Dept Rheumatol, Ghent, Belgium

[7] Charles Univ Prague, Inst Rheumatol, Prague, Czech Republic

[8] Charles Univ Prague, Dept Rheumatol, Prague, Czech Republic

[9] Hosp Italiano Buenos Aires & Univ Inst, Rheumatol Unit, Internal Med Serv, Buenos Aires, DF, Argentina

[10] PSOAPS Psoriasis Clin & Res Ctr, Dermatol Country, Guadalajara, Mexico

[11] Novartis Healthcare Pvt Ltd, Clin Project Management, Hyderabad, India

[12] Novartis Healthcare Pvt Ltd, Biostat, Hyderabad, India

[13] Novartis Pharmaceut, Biostat, East Hanover, NH USA

[14] FAU Erlangen Nurnberg & Univ Klinikum Erlangen, Dept Internal Med 3, Erlangen, Germany

[15] Vrije Univ, Amsterdam UMC, Dept Epidemiol & Data Sci, Amsterdam, Netherlands

来源：

ANNALS OF THE RHEUMATIC DISEASES | 2023年 / 82卷

关键词：

Psoriatic arthritis; bDMARD;

D O I：

10.1136/annrheumdis-2023-eular.2548

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

POS0225

引用

页码：340 / 341

页数：2

共 50 条

[1] How Well Does Ultrasound-assessed Synovitis in Reduced Joint Sets Predict the Response to Secukinumab in Patients with Active Psoriatic Arthritis and Inadequate Response to Conventional DMARDs? - Exploratory Results from a Phase 3b Study
D'Agostino, Maria-Antonietta
Conaghan, Philip G.
Gaillez, Corine
Naredo, Esperanza
Mandl, Peter
Carron, Philippe
Senolt, Ladislav
Eduardo Rosa, Javier
Lopez Rdz, Alejandra
Goyanka, Punit
Sahoo, Braja Gopal
Bao, Weibin
Schett, Georg
Boers, Maarten
ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 4246 - 4248
[2] REDUCED JOINT SYNOVITIS ASSESSMENT VERSUS THE GLOBAL EULAR OMERACT SYNOVITIS SCORE (GLOESS) TO PREDICT THE RESPONSE TO SECUKINUMAB IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS AND INADEQUATE RESPONSE TO CONVENTIONAL DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS: EXPLORATORY RESULTS FROM THE ULTIMATE TRIAL
Conaghan, Philip G.
D'agostino, Maria-Antonietta
Boers, Maarten
Naredo, Esperanza
Mandl, Peter
Carron, Philippe
Backhaus, Marina
Lopez-Rodriguez, Alejandra
Hanova, Petra
Goyanka, Punit
Sahoo, Braja G.
Gaillez, Corine
Bao, Weibin
RHEUMATOLOGY, 2023, 62
[3] REDUCED JOINT SYNOVITIS ASSESSMENT VERSUS THE GLOBAL EULAR OMERACT SYNOVITIS SCORE (GLOESS) TO PREDICT THE RESPONSE TO SECUKINUMAB IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS AND INADEQUATE RESPONSE TO CONVENTIONAL DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS: EXPLORATORY RESULTS FROM THE ULTIMATE TRIAL
D'Agostino, M. A.
Boers, M.
Schett, G.
Conaghan, P. G.
Naredo, E.
Mandl, P.
Carron, P.
Backhaus, M.
Lopez-Rodriguez, A.
Hanova, P.
Goyanka, P.
Sahoo, B. G.
Gaillez, C.
Bao, W.
ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 195 - 196
[4] Effect of guselkumab on serum biomarkers in patients with active psoriatic arthritis and inadequate response to tumor necrosis factor inhibitors: results from the COSMOS phase 3b study
Georg Schett
Warner Chen
Sheng Gao
Soumya D. Chakravarty
May Shawi
Frederic Lavie
Miriam Zimmermann
Mohamed Sharaf
Laura C. Coates
Stefan Siebert
Arthritis Research & Therapy, 25
[5] Effect of guselkumab on serum biomarkers in patients with active psoriatic arthritis and inadequate response to tumor necrosis factor inhibitors: results from the COSMOS phase 3b study
Schett, Georg
Chen, Warner
Gao, Sheng
Chakravarty, Soumya D.
Shawi, May
Lavie, Frederic
Zimmermann, Miriam
Sharaf, Mohamed
Coates, Laura C.
Siebert, Stefan
ARTHRITIS RESEARCH & THERAPY, 2023, 25 (01)
[6] Sustained response to guselkumab regardless of baseline characteristics in patients with active psoriatic arthritis and inadequate response to TNF inhibitors: results from the phase 3b COSMOS clinical trial
Mcinnes, Iain B.
Sewerin, Philipp
Sharaf, Mohamed
Efficace, Michela
Lavie, Frederic
Zimmermann, Miriam
Coates, Laura C.
RMD OPEN, 2024, 10 (04):
[7] SUSTAINED RESPONSE TO GUSELKUMAB REGARDLESS OF BASELINE DEMOGRAPHIC, DISEASE, AND MEDICATION CHARACTERISTICS IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS AND AN INADEQUATE RESPONSE TO TNF INHIBITORS: RESULTS FROM A PHASE 3B TRIAL
Mcinnes, I.
Sewerin, P.
Sharaf, M.
Efficace, M.
Shawi, M.
Perate, M.
Zimmermann, M.
Coates, L.
ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1784 - 1785
[8] Sustained Response to Guselkumab Regardless of Baseline Demographic, Disease, and Medication Characteristics in Patients With Active Psoriatic Arthritis and an Inadequate Response to TNF Inhibitors: Results From a Phase 3B Trial
McInnes, Iain
Sewerin, Philipp
Richard, Nicolas
Sharaf, Mohamed
Efficace, Michela
Shawi, May
Perate, Michelle
Zimmermann, Miriam
Coates, Laura
JOURNAL OF RHEUMATOLOGY, 2023, 50 (07) : 80 - 80
[9] Sustained Response to Guselkumab Regardless of Baseline Demographic, Disease, and Medication Characteristics in Patients with Active Psoriatic Arthritis and an Inadequate Response to TNF Inhibitors: Results from a Phase 3b Trial
McInnes, Iain B.
Sewerin, Philipp
Sharaf, Mohamed
Efficace, Michela
Shawi, May
Perate, Michelle
Zimmermann, Miriam
Coates, Laura
ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 4241 - 4244
[10] Response to secukinumab on synovitis using Power Doppler ultrasound in psoriatic arthritis: 12-week results from a phase III study, ULTIMATE
D'Agostino, Maria Antonietta
Schett, Georg
Lopez-Rdz, Alejandra
Senolt, Ladislav
Fazekas, Katalin
Burgos-Vargas, Ruben
Maldonado-Cocco, Jose
Naredo, Esperanza
Carron, Philippe
Duggan, Anne-Marie
Goyanka, Punit
Boers, Maarten
Gaillez, Corine
RHEUMATOLOGY, 2022, 61 (05) : 1867 - 1876

← 1 2 3 4 5 →